Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Osteoporos Int. 2010 Aug 4;22(5):1493–1501. doi: 10.1007/s00198-010-1365-4

Table 4.

Correlates of treatment initiation and persistence with therapy (among those recommended treatment)

Initiated osteoporosis treatment
Persisted with osteoporosis treatment
Unadjusted N=137
Adjusteda N=114
Unadjusted N=114
Adjusteda N=97
OR 95% CI p Value OR 95% CI p Value OR 95% CI p-value OR (95% CI) p Value
Age, mean (SD) 0.99 0.94 1.05 0.77 0.96 0.90 1.03 0.24
Male 1.57 0.19 13.22 0.68 >999.999 <0.001 >999.999 0.97
Smoking (current) 1.75 0.60 5.08 0.31 1.64 0.42 6.43 0.48
Glucocorticoid treatment (current) 0.67 0.17 2.63 0.57 1.07 0.12 9.22 0.96
Family history in first degree relative 2.40 0.76 7.58 0.14 2.33 0.55 9.91 0.25 0.50 0.15 1.67 0.26
Prior fragility fracture 1.50 0.58 3.84 0.40 0.59 0.18 1.97 0.39
Early menopause 0.89 0.27 2.93 0.85 1.00 0.20 4.98 1.00
Correctly report DXA test found osteoporosis 3.29 1.24 8.74 0.02 4.33 1.24 15.09 0.02 0.93 0.19 4.63 0.93
Health status is good to excellentb 1.06 0.43 2.65 0.90 3.00 0.77 11.72 0.11 4.98 0.51 48.92 0.169
Perceptions about benefitsc, Z-score 1.52 1.18 1.96 0.001 1.45 1.11 1.90 0.006 1.86 1.27 2.73 0.001 1.80 1.19 2.73 0.006
Drug treatment barriers (agreement)
I am taking too many medications 0.29 0.09 0.97 0.04 0.41 0.07 2.25 0.30 0.37 0.07 2.02 0.25
I have stomach problems that limit to the types of medicine I can tolerate 1.07 0.39 2.98 0.89 0.15 0.04 0.56 0.004 0.32 0.06 1.68 0.178
a

Adjusted for variables included in the table (p<0.2 in unadjusted analysis)

b

Self-report health status is excellent, very good, or good (compared to fair or poor)

c

Based on responses to three items on a five-point scale from strongly agree to strongly disagree: “Medical treatment can reduce the risk of broken bones”, “I would feel good about taking medications for osteoporosis”, “Medication can build strong bones”. Higher scores indicate stronger beliefs in the benefits of osteoporosis pharmacotherapy